touchENDOCRINOLOGY joins Professor Irene Lambrinoudaki (National and Kapodistrian University of Athens, Greece), at WCO21 to discuss her presentation on the treatment of menopausal and vulvovaginal atrophy symptoms, and menopausal hormone therapy in treating menopause-associated bone loss.
Questions
1. How are bothersome menopausal and vulvovaginal atrophy symptoms currently treated? (00:30-02:00)
2. What are the benefits and risks of menopausal hormone therapy in treating menopause-associated bone loss, including factors which impact outcomes? (02:00-04:06)
Disclosures: Irene Lambrinoudak has no financial or non-financial conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Sophie Nickelson.
Filmed in coverage of the WCO21 Annual Meeting.
